microRNA 3939 (MIR3939)

microRNA 3939 is a member of the human microRNA family, a class of short (approximately 20–24 nucleotide), single-stranded non-coding RNAs that regulate gene expression post-transcriptionally[1][4]. Canonical microRNA biogenesis involves transcription by RNA polymerase II, cleavage by Drosha and Dicer nucleases, and assembly into the RNA-induced silencing complex (RISC), targeting specific mRNAs for translation inhibition or destabilization[1][4]. MicroRNAs are functionally diverse, but specific biological roles, disease involvement, or drug interactions of MIR3939 have not been clinically characterized or validated in public databases as of the current literature and dataset reviews. Most available sources confirm only its basic classification and genomic annotation[1].\n\nKey clarification:\n- MIR3939 is a microRNA gene, not a receptor, enzyme, transporter, or conventional therapeutic target.\n- There is no evidence that MIR3939 is used, proposed, or studied as a drug target or diagnostic biomarker, nor implicated in a specific disease role in any referenced biological or clinical studies[1][2][4].\n- Consequently, *is_target* is false and *is_incorrect* is true (not a conventional therapeutic target, may be inadvertently listed due to overinclusive naming or lack of specific biological role information).

Other names

hsa-mir-3939mir-3939MIR3939